Bipartisan group of attorneys general push for Medicare to cover Alzheimer’s treatments

Twenty-six attorneys general on both sides of the aisle called on Medicare on Monday to cover antibody-based Alzheimer’s treatments like Eisai and Biogen’s Leqembi (lecanemab) without restrictions and to reverse a controversial policy that limits coverage to patients in clinical trials.

Gentner Drummond

The letter, led…

Click here to view original post